Janus II Feasibility
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Robin Germany, MD
ZOLL Respicardia
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Insomnia and Sleep Institute of Arizona Llc
Scottsdale, Arizona, United States
Sriharsha Vajjala, MDRecruiting - the University of Michigan Health-West
Wyoming, Michigan, United States
Timothy Daum, MDRecruiting - the Ohio State University
Columbus, Ohio, United States
Ralph Augostini, MDRecruiting - Houston Methodist Institute
Houston, Texas, United States
Paul Schurmann, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Aug 2025
- Primary completion
- 30 Apr 2028
- Completion
- 31 Dec 2034
- Last update posted
- 21 Oct 2026
- Registered enrollment
- 40
- Registry id
- NCT06556693
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.